
Drépanocytose : Kéni Piperol met les voiles pour la cause
Drépanocytose : ma rencontre avec Kéni Piperol à la Route du Rhum, son projet Drépavoile et les avancées de la recherche clinique. Où en est-on ?
The final version of ICH E6(R3) is a game-changer for clinical research.

The final version of ICH E6(R3) is a game-changer for clinical research. More flexible, logical, and digitally native, it encourages stakeholders to rethink traditional habits.
However, let’s be honest: navigating the annexes, new concepts, and compliance obligations isn’t always straightforward. To bridge this gap, TransCelerate offers a suite of practical tools designed to help you understand and apply this new version of Good Clinical Practice (GCP) effectively.
ICH E6(R3) is the latest revision of Good Clinical Practice guidelines, adopted by the International Council for Harmonisation (ICH) to modernize trial design and execution.
Its objective is clear: make research more proportionate to risks, more quality-focused (Quality by Design), and better adapted to technological shifts like decentralized trials and real-world data.
The text is built around two pillars: Annex 1, focusing on general GCP principles applicable to all trials, and Annex 2 (currently being finalized), focusing on modern trial types such as decentralized, hybrid, or real-world evidence trials. The core philosophy is simple: we no longer follow rigid rules blindly; we adapt them to the actual context of each study.
TransCelerate BioPharma is a non-profit organization bringing together major pharmaceutical companies to simplify and harmonize clinical trials.
They have developed a library of free resources to help teams implement R3 principles in a structured way. Here is how these resources break down:
Building a solid trial starts from day one. TransCelerate offers:
The R3 version emphasizes a risk-based approach.
Data is the heart of compliance. TransCelerate provides:
A risk-based monitoring strategy is now essential. Resources include:
The shift also impacts sites. TransCelerate has published a clear summary of GCP changes for investigation teams, covering:
ICH E6(R3) invites us to conduct clinical research that is more thoughtful, efficient, and aligned with modern reality. TransCelerate offers the tools to apply these requirements without drowning in theory. If you want to master ICH E6(R3) while working smarter, not harder, their library is the place to start.
Thinking about moving into Clinical Research Project Management? Understand the differences between a CRA and a Project Manager and identify the skills you need to develop today by clicking here.